Compare $AEON vs $INAB | Chartloom

Compare

$AEON vs $INAB

AEON Biopharma Inc · IN8bio Inc

AEON

AEON Biopharma Inc

INAB

IN8bio Inc

Compare $AEON vs $INAB

Comparing AEON Biopharma Inc and IN8bio Inc

AEONAEON Biopharma Inc

INABIN8bio Inc

AEONAEON Biopharma Inc

Market cap

$10M

P/E (TTM)

—

Forward P/E (NTM)

—

Forward P/S (NTM)

—

Rev growth (TTM)

—

YTD performance

-75.1%

52W performance

-70.0%

FCF yield

-133.0%

INABIN8bio Inc

Market cap

$13M

P/E (TTM)

—

Forward P/E (NTM)

—

Forward P/S (NTM)

—

Rev growth (TTM)

—

YTD performance

-45.5%

52W performance

-44.4%

FCF yield

-110.6%

Add ticker

Add up to 1 more ticker to compare

Relative performance

Each ticker starts at 100. 110 means +10% from the start of this window — not a $110 share price.

AEON

INAB

Detailed metrics comparison

AEON

AEON Biopharma Inc

INAB

IN8bio Inc

Market Cap

AEON$10M

INAB$13M

Enterprise Value

AEON$9M

INAB$-5M

Price

AEON$0.28

INAB$1.34

P/E Ratio

AEONN/A

INABN/A

P/S Ratio

AEON0.00x

INAB0.00x

EV/Sales

AEON0.00x

INAB0.00x

EV/EBITDA

AEON0.08x

INAB0.00x

P/B Ratio

AEON4.90x

INAB0.75x

P/FCF Ratio

AEONN/A

INABN/A

EV/FCF

AEON-0.63x

INAB0.32x

PEG Ratio

AEONN/A

INABN/A

Forward P/E (NTM)

AEONN/A

INABN/A

Forward P/S (NTM)

AEONN/A

INABN/A

Revenue (TTM)

AEON$0

INAB$0

Revenue Growth (YoY)

AEONN/A

INABN/A

Forward Rev Growth

AEON3564.8%

INAB1211.4%

Gross Margin (TTM)

AEON0.0%

INAB0.0%

Operating Margin (TTM)

AEON0.0%

INAB0.0%

EBITDA Margin (TTM)

AEON0.0%

INAB0.0%

Net Margin (TTM)

AEON0.0%

INAB0.0%

FCF Margin (TTM)

AEONN/A

INABN/A

Net Income (TTM)

AEON$-55M

INAB$-19M

FCF (TTM)

AEON$-14M

INAB$-15M

EPS (TTM)

AEON-$1.08

INAB-$0.96

ROE (TTM)

AEON-174.1%

INAB-9118.0%

ROA (TTM)

AEON-75776.0%

INAB-7693.0%

ROIC (TTM)

AEON-180.4%

INAB-9006.0%

Cash

AEON$3M

INAB$18M

Debt

AEON$2M

INAB$126K

Net Cash/Debt

AEON$2M

INAB$18M

Current Ratio (TTM)

AEON0.54x

INAB8.21x

Quick Ratio (TTM)

AEON0.47x

INAB8.13x

Debt/Equity (TTM)

AEON10.28x

INAB0.01x

Debt/Assets (TTM)

AEON0.0%

INAB0.0%

Interest Coverage (TTM)

AEONN/A

INABN/A

Net Debt/EBITDA (TTM)

AEON0.00x

INAB0.00x

Beta

AEON0.64

INAB0.24

52W Performance

AEON-70.0%

INAB-44.4%

YTD Performance

AEON-75.1%

INAB-45.5%

% from 52W High

AEON-81.0%

INAB-50.9%

% from 52W Low

AEON55.8%

INAB52.3%

Asset Turnover (TTM)

AEON0.00x

INAB0.00x

FCF Yield (TTM)

AEON-133.0%

INAB-110.6%

Earnings Yield (TTM)

AEON-532.7%

INAB-141.4%

Dividend Yield (TTM)

AEONN/A

INABN/A

Rule of 40

AEON0.0

INAB0.0

EV/GP/RG

AEONN/A

INABN/A

Ticker research

View AEON research View INAB research

Metric	AEON AEON Biopharma Inc	INAB IN8bio Inc
Market & Valuation
Market Cap	$10M	$13M
Enterprise Value	$9M	$-5M
Price	$0.28	$1.34
P/E Ratio	N/A	N/A
P/S Ratio	0.00x	0.00x
EV/Sales	0.00x	0.00x
EV/EBITDA	0.08x	0.00x
P/B Ratio	4.90x	0.75x
P/FCF Ratio	N/A	N/A
EV/FCF	-0.63x	0.32x
PEG Ratio	N/A	N/A
Forward P/E (NTM)	N/A	N/A
Forward P/S (NTM)	N/A	N/A
Revenue & Growth
Revenue (TTM)	$0	$0
Revenue Growth (YoY)	N/A	N/A
Forward Rev Growth	3564.8%	1211.4%
Profitability
Gross Margin (TTM)	0.0%	0.0%
Operating Margin (TTM)	0.0%	0.0%
EBITDA Margin (TTM)	0.0%	0.0%
Net Margin (TTM)	0.0%	0.0%
FCF Margin (TTM)	N/A	N/A
Net Income (TTM)	$-55M	$-19M
FCF (TTM)	$-14M	$-15M
EPS (TTM)	-$1.08	-$0.96
ROE (TTM)	-174.1%	-9118.0%
ROA (TTM)	-75776.0%	-7693.0%
ROIC (TTM)	-180.4%	-9006.0%
Financial Health
Cash	$3M	$18M
Debt	$2M	$126K
Net Cash/Debt	$2M	$18M
Current Ratio (TTM)	0.54x	8.21x
Quick Ratio (TTM)	0.47x	8.13x
Debt/Equity (TTM)	10.28x	0.01x
Debt/Assets (TTM)	0.0%	0.0%
Interest Coverage (TTM)	N/A	N/A
Net Debt/EBITDA (TTM)	0.00x	0.00x
Performance
Beta	0.64	0.24
52W Performance	-70.0%	-44.4%
YTD Performance	-75.1%	-45.5%
% from 52W High	-81.0%	-50.9%
% from 52W Low	55.8%	52.3%
Efficiency & Yields
Asset Turnover (TTM)	0.00x	0.00x
FCF Yield (TTM)	-133.0%	-110.6%
Earnings Yield (TTM)	-532.7%	-141.4%
Dividend Yield (TTM)	N/A	N/A
Other
Rule of 40	0.0	0.0
EV/GP/RG	N/A	N/A
Ticker research	View AEON research	View INAB research

Valuation

P/S Ratio

AEON

0.00x

INAB

0.00x

EV/FCF

AEON

-0.63x

INAB

0.32x

Growth & revenue

Forward Revenue Growth

AEON

3564.8%

INAB

1211.4%

Profitability & performance

Gross Margin

AEON

0.0%

INAB

0.0%

ROE

AEON

-174.1%

INAB

-9118.0%

FCF Yield %

INAB

-110.6%

AEON

-133.0%

52-Week Performance

INAB

-44.4%

AEON

-70.0%

Detailed metrics comparison

AEON

AEON Biopharma Inc

INAB

IN8bio Inc

Market Cap

AEON$10M

INAB$13M

Enterprise Value

AEON$9M

INAB$-5M

Price

AEON$0.28

INAB$1.34

P/E Ratio

AEONN/A

INABN/A

P/S Ratio

AEON0.00x

INAB0.00x

EV/Sales

AEON0.00x

INAB0.00x

EV/EBITDA

AEON0.08x

INAB0.00x

P/B Ratio

AEON4.90x

INAB0.75x

P/FCF Ratio

AEONN/A

INABN/A

EV/FCF

AEON-0.63x

INAB0.32x

PEG Ratio

AEONN/A

INABN/A

Forward P/E (NTM)

AEONN/A

INABN/A

Forward P/S (NTM)

AEONN/A

INABN/A

Revenue (TTM)

AEON$0

INAB$0

Revenue Growth (YoY)

AEONN/A

INABN/A

Forward Rev Growth

AEON3564.8%

INAB1211.4%

Gross Margin (TTM)

AEON0.0%

INAB0.0%

Operating Margin (TTM)

AEON0.0%

INAB0.0%

EBITDA Margin (TTM)

AEON0.0%

INAB0.0%

Net Margin (TTM)

AEON0.0%

INAB0.0%

FCF Margin (TTM)

AEONN/A

INABN/A

Net Income (TTM)

AEON$-55M

INAB$-19M

FCF (TTM)

AEON$-14M

INAB$-15M

EPS (TTM)

AEON-$1.08

INAB-$0.96

ROE (TTM)

AEON-174.1%

INAB-9118.0%

ROA (TTM)

AEON-75776.0%

INAB-7693.0%

ROIC (TTM)

AEON-180.4%

INAB-9006.0%

Cash

AEON$3M

INAB$18M

Debt

AEON$2M

INAB$126K

Net Cash/Debt

AEON$2M

INAB$18M

Current Ratio (TTM)

AEON0.54x

INAB8.21x

Quick Ratio (TTM)

AEON0.47x

INAB8.13x

Debt/Equity (TTM)

AEON10.28x

INAB0.01x

Debt/Assets (TTM)

AEON0.0%

INAB0.0%

Interest Coverage (TTM)

AEONN/A

INABN/A

Net Debt/EBITDA (TTM)

AEON0.00x

INAB0.00x

Beta

AEON0.64

INAB0.24

52W Performance

AEON-70.0%

INAB-44.4%

YTD Performance

AEON-75.1%

INAB-45.5%

% from 52W High

AEON-81.0%

INAB-50.9%

% from 52W Low

AEON55.8%

INAB52.3%

Asset Turnover (TTM)

AEON0.00x

INAB0.00x

FCF Yield (TTM)

AEON-133.0%

INAB-110.6%

Earnings Yield (TTM)

AEON-532.7%

INAB-141.4%

Dividend Yield (TTM)

AEONN/A

INABN/A

Rule of 40

AEON0.0

INAB0.0

EV/GP/RG

AEONN/A

INABN/A

Ticker research

View AEON research View INAB research

Metric	AEON AEON Biopharma Inc	INAB IN8bio Inc
Market & Valuation
Market Cap	$10M	$13M
Enterprise Value	$9M	$-5M
Price	$0.28	$1.34
P/E Ratio	N/A	N/A
P/S Ratio	0.00x	0.00x
EV/Sales	0.00x	0.00x
EV/EBITDA	0.08x	0.00x
P/B Ratio	4.90x	0.75x
P/FCF Ratio	N/A	N/A
EV/FCF	-0.63x	0.32x
PEG Ratio	N/A	N/A
Forward P/E (NTM)	N/A	N/A
Forward P/S (NTM)	N/A	N/A
Revenue & Growth
Revenue (TTM)	$0	$0
Revenue Growth (YoY)	N/A	N/A
Forward Rev Growth	3564.8%	1211.4%
Profitability
Gross Margin (TTM)	0.0%	0.0%
Operating Margin (TTM)	0.0%	0.0%
EBITDA Margin (TTM)	0.0%	0.0%
Net Margin (TTM)	0.0%	0.0%
FCF Margin (TTM)	N/A	N/A
Net Income (TTM)	$-55M	$-19M
FCF (TTM)	$-14M	$-15M
EPS (TTM)	-$1.08	-$0.96
ROE (TTM)	-174.1%	-9118.0%
ROA (TTM)	-75776.0%	-7693.0%
ROIC (TTM)	-180.4%	-9006.0%
Financial Health
Cash	$3M	$18M
Debt	$2M	$126K
Net Cash/Debt	$2M	$18M
Current Ratio (TTM)	0.54x	8.21x
Quick Ratio (TTM)	0.47x	8.13x
Debt/Equity (TTM)	10.28x	0.01x
Debt/Assets (TTM)	0.0%	0.0%
Interest Coverage (TTM)	N/A	N/A
Net Debt/EBITDA (TTM)	0.00x	0.00x
Performance
Beta	0.64	0.24
52W Performance	-70.0%	-44.4%
YTD Performance	-75.1%	-45.5%
% from 52W High	-81.0%	-50.9%
% from 52W Low	55.8%	52.3%
Efficiency & Yields
Asset Turnover (TTM)	0.00x	0.00x
FCF Yield (TTM)	-133.0%	-110.6%
Earnings Yield (TTM)	-532.7%	-141.4%
Dividend Yield (TTM)	N/A	N/A
Other
Rule of 40	0.0	0.0
EV/GP/RG	N/A	N/A
Ticker research	View AEON research	View INAB research